Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice.
about
Histone deacetylase inhibitor (HDACi) suberoylanilide hydroxamic acid (SAHA)-mediated correction of α1-antitrypsin deficiencyEpigenome-modifying tools in asthmaTumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.Thrombin down-regulates tissue factor pathway inhibitor expression in a PI3K/nuclear factor-κB-dependent manner in human pleural mesothelial cells.Regulation of immune responses by histone deacetylase inhibitorsTissue factor expression by myeloid cells contributes to protective immune response against Mycobacterium tuberculosis infection.Organizing empyema induced in mice by Streptococcus pneumoniae: effects of plasminogen activator inhibitor-1 deficiencyThe histone deacetylase inhibitor trichostatin A suppresses murine innate allergic inflammation by blocking group 2 innate lymphoid cell (ILC2) activation.Targeting TFPI for hemophilia treatment.Therapeutic effects of histone deacetylase inhibitors in a murine asthma modelPlasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.Epigenetic regulation of inflammation: progressing from broad acting histone deacetylase (HDAC) inhibitors to targeting specific HDACs.Eosinophil apoptosis as a therapeutic target in allergic asthma.The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.New insights into lung development and diseases: the role of microRNAs.Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.Association between histone hyperacetylation status in memory T lymphocytes and allergen-induced eosinophilic airway inflammation.Alternative approaches for the treatment of airway diseases: focus on nanoparticle medicine.Endothelial cell protein C receptor opposes mesothelioma growth driven by tissue factor.Human pulmonary 3D models for translational research.Evaluation of inflammatory and immune responses in long-term cultured human precision-cut lung slices.Inhibition of Glycogen Synthase Kinase 3β Blocks Mesomesenchymal Transition and Attenuates Streptococcus pneumonia-Mediated Pleural Injury in Mice.Targeting transcription factor lysine acetylation in inflammatory airway diseasesControversies Surrounding the Potential Use of Histone Deacetylase Inhibitors for the Treatment of Asthma
P2860
Q24619820-8F608465-570A-4947-948C-EB502FB121C2Q28083520-E8574486-D6C2-4994-9C68-6C7B5DDB66BBQ35579053-820347F6-538C-4048-B773-EA2A94F52C15Q35816399-31E152A6-5280-4936-8C34-7E6F55BB835DQ35855571-8D2CCDE0-08D3-48D2-8320-7E0F457A0501Q36540595-5AFA2573-BBAD-43C0-817D-21102D519F13Q36978644-DF142F00-2E0D-4305-9BE5-6186B2D2DF8FQ37085681-7394CE51-D972-4B07-84EE-D4FF7C551990Q37108074-FEA682D8-559D-4562-A9F1-22511747FAC2Q37358582-E800DD1D-0D69-473B-8A03-2FF900B5A929Q37596163-DBCF7D0C-97B2-474B-9441-010F29257637Q38076074-9B45628F-8117-44A9-BFDF-9FC8BEBF66B1Q38154740-A8517AB8-FF6C-476E-B867-19B8F2577466Q38260795-7981EEEE-4ACE-4A02-A866-5440EE461B2BQ38309155-DC78A42C-08CC-453F-9281-A111ACF21781Q38811516-F3118EA2-E153-492D-9FA1-1F23D227E9B9Q38893203-CEE1ED0D-7C4A-4D24-B0D3-4CBDA56E6833Q38893756-8B13BD7B-16FB-42B9-9EEF-B804821F1249Q39173889-2928262F-5B62-4C2C-A0AB-2AB4BC70DBF1Q40069891-17AB3814-1663-4218-8BF2-DF55E0C00210Q40435757-573D6658-BF9C-4600-B6CA-1852EA1DCD81Q47599408-64F73577-9CF7-477E-A67D-961F45ED30D5Q57712790-B2BE5D7D-5463-4429-A3ED-C78BFD6F541DQ58690453-26C8B94F-FFD5-447A-8DF2-090FC9631EBF
P2860
Tissue factor pathway inhibitor attenuates the progression of malignant pleural mesothelioma in nude mice.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Tissue factor pathway inhibito ...... ral mesothelioma in nude mice.
@ast
Tissue factor pathway inhibito ...... ral mesothelioma in nude mice.
@en
type
label
Tissue factor pathway inhibito ...... ral mesothelioma in nude mice.
@ast
Tissue factor pathway inhibito ...... ral mesothelioma in nude mice.
@en
prefLabel
Tissue factor pathway inhibito ...... ral mesothelioma in nude mice.
@ast
Tissue factor pathway inhibito ...... ral mesothelioma in nude mice.
@en
P2093
P2860
P356
P1476
Tissue factor pathway inhibito ...... ral mesothelioma in nude mice.
@en
P2093
Kathy Koenig
L Vijaya Mohan Rao
LaTerrica Williams
Steven Idell
Timothy Allen
Torry A Tucker
Usha Pendurthi
P2860
P304
P356
10.1165/RCMB.2010-0276OC
P577
2011-08-18T00:00:00Z